215476 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2023-03-28 |
| Register Year | 2006 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | OMALIZUMAB |
| Trade Name | XOLAIR 150MG Powder for injection |
| Strength Unit | mg |
| Pharmaceutical Form | powder for solution for injection |
| Administration Route | Subcutaneous use |
| Atc Code1 | R03DX05 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $1796.85 |
| Shelf Life | 48 Months |
| Marketing Company | NOVARTIS |
| Marketing Country | Switzerland |
| Manufacture Name | NOVARTIS |
| Manufacture Country | Switzerland |
| Secondry package manufacture | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO |
| Main Agent | Novartis Saudi Limited |
| Secosnd Agent | |
| Third Agent | |
| Visits | 215476 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| XOLAIR 150MG Powder for injection | $1796.85 | 215476 visits | 2023-03-28 |